Zentrum für Integrative Onkologie

What Zentrum für Integrative Onkologie does

Zentrum für Integrative Onkologie (ZIO AG) is a Swiss outpatient oncology center founded around 2015 as a subsidiary of NSN Medical AG (Winterthur). ZIO combines evidence-based conventional tumor treatment — chemotherapy, immunotherapy, targeted therapy, radiation and surgery coordination — with complementary medicine disciplines including anthroposophic medicine, acupuncture/Traditional Chinese Medicine (TCM), homeopathy, hyperthermia, orthomolecular medicine, nutritional therapy, sports therapy, and psycho-oncology. Patients are presented before therapy decisions at a weekly interdisciplinary tumorboard, with diagnostic and therapeutic plans individualized according to international guidelines. The center positions itself as the only outpatient facility in Switzerland offering simultaneous access to physicians trained in both conventional oncology and multiple complementary medicine disciplines from a single integrated setting.

The core service offering is a comprehensive cancer-treatment pathway delivered through a portfolio of "Themensprechstunden" (topic consultation hours) covering approximately 16 specialty areas, plus dedicated psycho-oncology, palliative care and second-opinion consultation services. ZIO operates from six physical outpatient locations across the Zurich metropolitan area (Zürich Hardturmstrasse as headquarters, Zürichsee/Richterswil, Winterthur, Uster, Glarus, and Oerlikon opening in mid-September 2026). The center is ISO 9001 and IQNet certified, employs 90+ staff, and recorded 19,000+ outpatient consultations in 2024 with projected volume of ~26,000 annually post-Oerlikon expansion.

ZIO's go-to-market is sales-led and referral-driven: a dedicated "Für Ärzte" (For Physicians) portal captures external physician referrals to the tumorboard, supplemented by direct patient self-referral and second-opinion appointment scheduling. Revenue is generated per-encounter through Swiss ambulatory care frameworks (TARMED), billed via basic and supplementary health insurance depending on treatment modality. Marketing channels include the multi-language public website (German, English, French, Italian, Russian, Arabic), patient testimonials, newsletter communications, earned media such as the TOP MED television program, and physician referral relationships. Active clinical research, with physicians publishing in specialist journals, reinforces the center's positioning beyond pure fee-for-service delivery.

Name

Zentrum für Integrative Onkologie

Legal name

ZIO AG

Website

https://zio.ch

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

ZIO AG operates Switzerland's leading outpatient integrative oncology center, combining conventional cancer treatment with complementary medicine across six locations in Zürich, Winterthur, Glarus, Uster, and Zürichsee. Founded in 2015, the center serves 19,000+ patients annually with a multidisciplinary tumorboard and dual-trained physicians.

Ownership category

akta.pro rank

Product category

Outpatient Integrative Oncology Services

NAICS

Other Ambulatory Health Care Services (6219)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

Keywords

• Integrative oncology services
• Outpatient cancer treatment
• Complementary oncology medicine
• Hematology and oncology care
• Ambulatory oncology center

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Ambulatory Oncology Care: Revenue is generated through outpatient oncology consultations, diagnostic procedures, and treatment services including chemotherapy, immunotherapy, and complementary therapies. The center operates as an ambulatory oncology facility within the Swiss healthcare system, billing through Swiss health insurance frameworks.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Zentrum für Integrative Onkologie (ZIO AG) is a Swiss outpatient oncology center that delivers integrative cancer treatment combining conventional evidence-based oncology (chemotherapy, immunotherapy, radiation, surgery) with complementary medicine approaches (anthroposophic medicine, acupuncture/TCM, psycho-oncology, nutrition, hyperthermia, orthomolecular medicine). Services are delivered by physicians, nursing staff, and therapists trained in both conventional and complementary disciplines, supported by a weekly interdisciplinary tumorboard for individualized treatment planning.

Product overview

Zentrum für Integrative Onkologie (ZIO) is an outpatient oncology center operating as a single unified healthcare service rather than a software product. The organization provides integrative oncology treatment combining conventional tumor medicine with complementary therapies across six Swiss locations (Zürich, Zürichsee, Winterthur, Glarus, Uster, and Oerlikon). The core offering is comprehensive cancer treatment, supported by specialized consultation hours (Themensprechstunden) covering topics like anthroposophic medicine, nutrition, psycho-oncology, TCM, and more. Key service modules include the weekly Tumorboard for interdisciplinary treatment planning, Acupuncture/TCM for supporting conventional treatments, and Psycho-Oncology services for emotional and psychological support. With over 90 employees and approximately 19,000+ annual consultations, ZIO represents a holistic, multi-disciplinary approach to cancer care.

Differentiator

Problem solved

Functional benefit

Products and services

• Integrative Oncology Services
• Themensprechstunden (Specialized Consultation Hours)
• Akupunktur / TCM (Traditional Chinese Medicine)
• Psychoonkologie (Psycho-Oncology)
• Tumorboard (Multidisciplinary Tumor Board)
• Zweitmeinungssprechstunde (Second Opinion Consultation)

Quantifiable outcome

• 19,000+ outpatient consultations in 2024, projected to reach 26,000 annually after Oerlikon expansion
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• NSN Medical AGparent_companyOthersZIO AG is a company under NSN Medical AG (parent company). NSN Medical AG is based in Winterthur and is responsible for IT operations including data protection oversight, as indicated by the NSN Medical AG IT leadership contact on the data privacy page.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Klinik Im Park: Zurich private hospital under the Hirslanden group offering oncology services. Competes with ZIO for private-pay patients in the Zurich city catchment.
• Inselspital Bern (University Hospital Bern): Swiss university hospital with a major oncology department and clinical trial programs. Indirect competitor for complex oncology referrals and benchmark for evidence-based quality.
• Kantonsspital Winterthur (KSW): Major public hospital in Winterthur with a comprehensive oncology center. Operates one of ZIO's shared geographic markets and competes for general oncology referrals.
• University Hospital Zurich (USZ): Largest academic hospital in Zurich with a comprehensive oncology department and clinical trial infrastructure. Competes for complex oncology referrals and second-opinion cases in the same catchment area as ZIO.
• Klinik Hirslanden: Leading Swiss private hospital group with oncology services in Zurich. Competes for private-pay oncology patients and second-opinion cases against ZIO's ambulatory offering.

Emerging players

• Arcadia Praxisklinik: German outpatient clinic focused on integrative and biological cancer treatment. Operates an ambulatory-only model analogous to ZIO, though smaller and focused on the German market.
• Habichtswald-Klinik: German clinic specializing in integrative oncology and naturopathic cancer treatment. Comparable integrative model but smaller scale and located across the border in Kassel.

Direct peers

• Klinik Arlesheim: Swiss hospital in Arlesheim that combines anthroposophic medicine with conventional oncology and internal medicine. Closest comparable in Switzerland to ZIO's integrative model, though inpatient rather than purely ambulatory.
• Paracelsus Klinik (Paracelsus Hospitals Group): German hospital group that combines conventional medicine with complementary and naturopathic approaches, including oncology. Operates an integrative care model directly comparable to ZIO's positioning.

Others

• Krebsliga Schweiz (Swiss Cancer League): National non-profit umbrella organization for cancer patients in Switzerland. Not a direct competitor but shapes referral pathways, patient guidance, and the public narrative around integrative oncology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/zentrum-f%C3%BCr-integrative-onkologie

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zentrum für Integrative Onkologie